Literature DB >> 15602695

Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells.

Przemyslaw Blyszczuk1, Christian Asbrand, Aldo Rozzo, Gabriela Kania, Luc St-Onge, Marjan Rupnik, Anna M Wobus.   

Abstract

We present a new strategy for the differentiation of embryonic stem (ES) cells into insulin-producing cells via a multi-step process without selection and induction of nestin-positive cells. During ES cell differentiation, transcript levels of genes characteristic of early and mature beta cells including Pdx1, Pax4, insulin and islet amyloid pancreatic peptide are up regulated. Islet-like clusters are characterized by expression of C-peptide, insulin and partially cytokeratin 19 as well as by ion channel activity similar to that found in embryonic beta cells. Cells of islet-like clusters show glucose-dependent insulin release at terminal stage. At an intermediate stage, nestin is partially co-expressed with C-peptide and cytokeratin 19, whereas islet-like clusters at the terminal stage are nestin-negative. We conclude that expression of nestin and cytokeratin 19 is a normal property of ES cells preceding differentiation into C-peptide/insulin-producing cells without any selection for nestin-positive phenotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602695     DOI: 10.1387/ijdb.041904pb

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  22 in total

1.  Generation of pancreatic insulin-producing cells from embryonic stem cells - 'proof of principle', but questions still unanswered.

Authors:  A Rolletschek; G Kania; A M Wobus
Journal:  Diabetologia       Date:  2006-09-20       Impact factor: 10.122

Review 2.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

3.  [Therapy of diabetes mellitus. Pancreas transplantation, islet transplantation, stem cell and gene therapy].

Authors:  C Dieterle; M D Brendel; J Seissler; M Eckhard; R G Bretzel; R Landgraf
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

4.  Characterization of immortalized mesenchymal stem cells derived from foetal porcine pancreas.

Authors:  H Cao; Y Chu; H Zhu; J Sun; Y Pu; Z Gao; C Yang; S Peng; Z Dou; J Hua
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

5.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

6.  Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters.

Authors:  Ashleigh S Boyd; Kathryn J Wood
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

Review 7.  Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells.

Authors:  Dong Hyeon Lee; Hyung Min Chung
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

8.  In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells.

Authors:  A Eshpeter; J Jiang; M Au; R V Rajotte; K Lu; J S Lebkowski; A S Majumdar; G S Korbutt
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

9.  An efficient experimental strategy for mouse embryonic stem cell differentiation and separation of a cytokeratin-19-positive population of insulin-producing cells.

Authors:  O Naujok; F Francini; A Jörns; S Lenzen
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

10.  Enhancement of insulin-producing cell differentiation from embryonic stem cells using pax4-nucleofection method.

Authors:  Han-Tso Lin; Chung-Lan Kao; Kun-Hsiung Lee; Yuh-Lih Chang; Shih-Hwa Chiou; Fu-Ting Tsai; Tung-Hu Tsai; Dey-Chyi Sheu; Larry L T Ho; Hung-Hai Ku
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.